Learn our story about how we are independent and what is needed to keep thisquality operating. You might be able to donate to us so we can inform and share what matters faster.Learn More
AstraZeneca’s COVID-19 vaccine developed by the University of Oxford has been approved for use in the United Kingdom.
Recent approval means the large scale immunisation campaign will be boosted and bring life back to normal once and for all, fighting against the virus.
The United Kingdom ordered over 100 million doses from AstraZeneca, which is enough to vaccinate around 50 million people.
Trials for the vaccine were undertaken first in April and have since done large-scale clinical trials involving thousands of volunteers.
It is the second type of vaccine to be approved in the United Kingdom and is significantly cheaper and easy to deliver worldwide. The first is Pfizer’s BioNTech vaccine that was approved for use in December.
Have time to spare? If you liked this publication, please learn our story to support thisquality. Fund trustworthy news coming from official Government newswires and local voices inside communities.Contribute